Krishna Yeshwant, a GV General Partner, brings a unique blend of computer science and medicine to his investment approach. Starting with successful tech companies, he later merged his tech background with medicine, writing software to guide surgical procedures. Graduating from Harvard's MD/MBA program, he joined GV in its early days and led the fund's commitment to life sciences. Krishna's investments span healthcare, from care delivery to therapeutics, with notable involvements in Flatiron Health, Beam Therapeutics, and more. He's driven by the transformative potential of biology and aims to enhance clinical trials and modernize healthcare delivery through innovative software approaches.